These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27282578)

  • 21. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protecting APOBEC3G: a potential new target for HIV drug discovery.
    Stopak K; Greene WC
    Curr Opin Investig Drugs; 2005 Feb; 6(2):141-7. PubMed ID: 15751736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
    Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
    Curr HIV Res; 2018; 16(4):297-301. PubMed ID: 30338740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
    Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3G governs to ensure cellular oncogenic transformation.
    Garg A; Kaul D; Chauhan N
    Blood Cells Mol Dis; 2015 Oct; 55(3):248-54. PubMed ID: 26227855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC3G targets human T-cell leukemia virus type 1.
    Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
    Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
    Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
    Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
    Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
    J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
    Schröfelbauer B; Chen D; Landau NR
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3927-32. PubMed ID: 14978281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
    Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
    J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-IL6 (C/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G.
    Kinoshita SM; Taguchi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15022-7. PubMed ID: 18809921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
    Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
    J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model structure of human APOBEC3G.
    Zhang KL; Mangeat B; Ortiz M; Zoete V; Trono D; Telenti A; Michielin O
    PLoS One; 2007 Apr; 2(4):e378. PubMed ID: 17440614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex.
    Zhang S; Zhong L; Chen B; Pan T; Zhang X; Liang L; Li Q; Zhang Z; Chen H; Zhou J; Luo H; Zhang H; Bai C
    Antiviral Res; 2015 Oct; 122():20-7. PubMed ID: 26241003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A flow cytometry technique to study intracellular signals NF-kappaB and STAT3 in peripheral blood mononuclear cells.
    Lafarge S; Hamzeh-Cognasse H; Chavarin P; Genin C; Garraud O; Cognasse F
    BMC Mol Biol; 2007 Jul; 8():64. PubMed ID: 17663801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further investigation of simian immunodeficiency virus Vif function in human cells.
    Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; Beer BE; Marx PA; Gao F; Bibollet-Ruche F; Hahn BH; Malim MH
    J Virol; 2004 Nov; 78(21):12041-6. PubMed ID: 15479843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
    Zhang H
    Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
    Sheehy AM; Gaddis NC; Malim MH
    Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autophagy molecule Beclin 1 maintains persistent activity of NF-κB and Stat3 in HTLV-1-transformed T lymphocytes.
    Chen L; Liu D; Zhang Y; Zhang H; Cheng H
    Biochem Biophys Res Commun; 2015 Oct; 465(4):739-45. PubMed ID: 26319552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.